This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more
about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
Fregonese L, Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008;3:16.
de Serres FJ. Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. Environ Health Perspect. 2003;111(16):1851-1854.
Crystal RG. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest. 1990;85(5):1343-1352.
Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with α-antitrypsin deficiency between 1968 and 2003. Chest. 2005;128(3):1179-1186.
Kelbel T, Morris D, Walker D, Henao MP, Craig T. The allergist’s role in detection of severe alpha-1 antitrypsin deficiency. J Allergy Clin Immunol Pract. 2017. doi:10.1016/j.jaip.2017.01.008.
Sandhaus RA, Turino G, Brantly ML, et al. The diagnosis and management of alpha-1 antitrypsin deficiency in the adult. Chronic Obstr Pulm Dis. 2016;6(3):668-682.
American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818-900.
Strange C, Stoller JK, Sandhaus RA, Dickson R, Turino G. Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration. 2006;73(2):185-190.
Siri D, Farah H, Hogarth DK. Distinguishing alpha1-antitrypsin deficiency from asthma. Ann Allergy Asthma Immunol. 2013;111(6):458-464.
Rachelefsky G, Hogarth DK. Issues in the diagnosis of alpha 1-antitrypsin deficiency. J Allergy Clin Immunol. 2008;121(4):833-838.
Thelin T, Sveger T, McNeil TF. Primary prevention in a high-risk group: smoking habits in adolescents with homozygous alpha-1-antitrypsin deficiency (ATD). Acta Paediatr. 1996;85:1207-1212.
Bernspang E, Sveger T, Piitulainen E. Respiratory symptoms and lung function in 30-year old individuals with alpha-1 antitrypsin deficiency. Respir Med. 2007;101:1971-1976.
Data on file. Available from CSL Behring as DOF ZMR-001.
Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185(3):246-259.
Petrache I, Hajjar J, Campos M. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. Biologics. 2009;3:193-204.
Ferrarotti I, Thun GA, Zorzetto M, et al. Serum levels and genotype distribution of α1-antitrypsin in the general population. Thorax. 2012;67(8):669-774.
Schlade-Bartusiak K, Cox DW. Alpha1-Antitrypsin Deficiency. 2006 Oct 27 [Updated 2008 Feb 6]. In: Pagon RA, Adam MP, Bird TD, et al, eds. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2013.
Stocks JM, Brantly M, Pollock D, et al. Multi-center study: the biochemical efficacy, safety and tolerability of a new α1-proteinase inhibitor, Zemaira. COPD. 2006;3(1):17-23.
Data on file. Available from CSL Behring as DOF ZMR-002.